The Lancet Respiratory Medicine in conversation with
Ein Podcast von The Lancet Group
156 Folgen
-
Tuberculosis and the microbiome
Vom: 3.9.2019 -
Antibiotics and non-severe exacerbations of bronchiectasis in children
Vom: 16.8.2019 -
Use of extended-criteria donors for lung transplantation
Vom: 6.8.2019 -
α1-antitrypsin deficiency testing
Vom: 30.7.2019 -
Live-attenuated influenza vaccines in children
Vom: 24.6.2019 -
Clearing the air on ambient air pollution
Vom: 19.6.2019 -
A second look at FEAST
Vom: 12.6.2019 -
Intensive care units and the USA
Vom: 21.5.2019 -
A respiratory family affair
Vom: 17.4.2019 -
A global approach to children's asthma
Vom: 22.2.2019 -
The effectiveness of pleural manometry
Vom: 14.2.2019 -
Lung volume reduction and emphysema
Vom: 8.2.2019 -
Glimmers of hope for MDR-Tuberculosis treatment
Vom: 8.1.2019 -
Effectiveness of flu vaccine over time
Vom: 16.11.2018 -
Towards an International Pneumonia Network
Vom: 12.11.2018 -
Laparoscopic anti-reflux surgery and IPF
Vom: 2.11.2018 -
Improving the lives of patients with bronchiectasis
Vom: 20.9.2018 -
Deep learning and fibrotic lung disease
Vom: 17.9.2018 -
Critical care and infant nutrition
Vom: 15.9.2018 -
Precision medicine in ARDS
Vom: 3.8.2018
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
